Lumiliximab (Anti-FceR2 / CD23)
Lumiliximab (Anti-FceR2 / CD23) is a monoclonal antibody targeting CD23, that inhibits allergen-induced responses. MW: 145.5 KD.
| Trivial name | Anti-CD23 Recombinant Antibody |
| Catalog Number | A2501 |
| CAS# | 357613-86-6 |
| Size | 1mg*25 |
| Supplier Page | http://www.selleckchem.com/products/lumiliximab-anti-fcer2-cd23.html |